Biochemical and Biophysical Research Communications
Volume 291, Issue 5, 15 March 2002, Pages 1201-1207
Regular ArticleEffects of a β3-Adrenergic Agonist on Glucose Uptake and Leptin Expression and Secretion in Cultured Adipocytes from Lean and Overweight (Cafeteria) Rats
References (33)
- et al.
Time-dependent effects of a high-energy-yielding diet on the regulation of specific white adipose tissue genes
Biochem. Biophys. Res. Commun.
(2001) - et al.
Rapid inhibition of ob gene expression and circulating leptin levels in lean mice by the β3-adrenoceptor agonist BRL 35135A and ZD2079
Biochem. Biophys. Res. Commun.
(1996) - et al.
Up-regulation of a thermogenesis-related gene (UCP1) and down-regulation of PPARgamma and aP2 genes in adipose tissue: possible features of the antiobesity effects of a beta3-adrenergic agonist
Biochem. Pharmacol.
(2001) - et al.
Improvement of metabolic disorders and visceral fat obesity by the β3-adrenoceptor agonist (R*,R*)-(±)-methyl-4-[2-[2-hydroxy-2–3-chlorophenyl)ethylamino]-propyl]-phenoxyacetatehydrobromide (BRL 35135) in genetically obese rodents
Biochem. Pharmacol.
(1996) - et al.
Augmented expression of the obese gene in the adipose tissue from rats fed high-fat diet
Biochem. Biophys. Res. Commun.
(1995) - et al.
Transcriptional regulation of the leptin promoter by insulin-stimulated glucose metabolism in 3T3-L1 adipocytes
Biochem. Biophys. Res. Commun.
(2001) - et al.
Sinergism between insulin and low concentrations of isoproterenol in the stimulation of leptin release by cultured human adipose tissue
Metabolism: Clinical and Experimental
(2000) - et al.
DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet
Am. J. Physiol.
(1997) - et al.
Diazoxide restores β3-adrenergic receptor function in diet-induced obesity and diabetes
Endocrinology
(2000) - et al.
High fat feeding causes insulin resistance and a marked decrease in the expression of glucose transporters (Glut 4) in fat cells of rats
Endocrinology
(1991)
Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances
Ann. NY Acad. Sci.
(1999)
Central role of the adipocyte in the insulin resistance
J. Basic Clin. Physiol. Pharmacol.
(1998)
Development of beta3-adrenoceptor agonists for the treatment of obesity and diabetes-an update
Diabetes & Metabolism
(1999)
Potential anti-diabetic applications of a new molecule with affinity for β3-adrenoceptors
Life Sci.
(1996)
Effects on energy utilization of a β3-adrenergic agonist in rats fed on a cafeteria diet
Eating Weight Disord.
(1997)
Up-regulation of muscle UCP2 gene expression by a new beta-3 adrenoceptor agonist, trecadrine, in obese (cafeteria) rodents, but down-regulation in lean animals
Int. J. Obes. Relat. Metab. Disord.
(2000)
Cited by (0)
- 1
To whom correspondence and reprint requests should be addressed Fax: 948-425649. E-mail: [email protected].
Copyright © 2002 Elsevier Science (USA). All rights reserved.